Microbiome and immunotherapy in bladder cancer: The missing link
Understanding the microbiome's role in bladder cancer immunotherapy presents a promising avenue for optimizing treatment strategies. Further research is imperative to elucidate these relationships and translate findings into clinical practice, potentially leading to microbiome-targeted interventions to improve patient outcomes.
Authors
- Emmanuel Rüsch (ORCID: https://orcid.org/0000-0002-9312-3776)
- Bénédicte Franck (ORCID: https://orcid.org/0000-0001-8150-3467)
- Basila Ali
Institutions
- Université de Tours (FR)
- Centre Hospitalier Universitaire de Tours (FR)
Publication Details
- Journal
- The French Journal of Urology
- Published
- 2025-06-21
- DOI
- https://doi.org/10.1016/j.fjurol.2025.102922
- Citations
- 2
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.01